Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals
Deal Bird & Bird advises Gulermak Renewables Ltd on the acquisition of a 42.4 MW UK solar project

Jun 18 2025

Read More
News Bird & Bird wins Five Awards at the LMG Life Sciences Awards EMEA 2025

Jun 18 2025

Read More
Deal Bird & Bird advises Aibidia on its $28 million Series B funding round

Jun 17 2025

Read More
Deal Bird & Bird advises Hoivatilat Oyj on the purchase of a care facility portfolio

Jun 17 2025

Read More
Deal Bird & Bird advises PHINIA on cross-border acquisition of SEM

Jun 16 2025

Read More
News Bird & Bird Celebrates 38 Lawyers Named Global Leaders in IAM and WTR 2025 Rankings

Jun 12 2025

Read More

Related capabilities